What is the newly approved obesity pill in the United Arab Emirates, and who can get it?

The Emirates Drug Establishment has approved Foundayo (orforglipron), a once-daily oral weight-loss pill developed by Eli Lilly, offering an alternative to injections; however, it is not for general use and will only be prescribed under strict medical supervision—typically for adults with a BMI of 30 or higher, or those with a BMI above 27 who also have related conditions like Type 2 Diabetes, high blood pressure, or sleep apnea, especially if lifestyle changes alone have not worked. The treatment is expected to be prescribed mainly by specialists such as endocrinologists or internal medicine doctors, and its use will be closely monitored as part of a broader plan that still includes diet, exercise, and long-term health management. Would you consider a pill-based weight-loss treatment, or do you think lifestyle changes should always come first?

Add your Comment:

+